A Study of QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
Latest Information Update: 16 Jan 2024
At a glance
- Drugs Iparomlimab (Primary) ; Carboplatin; Cisplatin; Paclitaxel
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Qilu Pharmaceutical
- 10 Jan 2024 Status changed from recruiting to discontinued.
- 04 Dec 2022 Results (n=46 ) presented in a Qilu Pharmaceutical Media Release.
- 04 Dec 2022 According to a Qilu Pharmaceutical media release, data (n=46 ) were presented at the European Society for Medical Oncology (ESMO) Asia Congress 2022.